Advancements in next-generation sequencing (NGS) have transformed transcriptome and small RNA profiling, enabling gene expression studies and the identification of splice variants, isoforms and novel transcripts from challenging samples like liquid biopsies, FFPE tumors and exosomes. This enhances our understanding of molecular mechanisms and aids in identifying RNA variants as potential disease biomarkers. 

In this webinar, we will explore a complete workflow for miRNA biomarker discovery and verification using NGS and digital PCR (dPCR).